Enzymlogic Marks 10 Years Transforming Drug Discovery Through Kinetic Profiling

Today, we celebrate an extraordinary milestone in our journey, and I can't help but feel profound gratitude and excitement as I reflect on these incredible ten years of achievements, innovation, and collaboration!

Enzymlogic , from its inception, has been committed to transforming the landscape of the pharmaceutical industry, and today, on our tenth anniversary, we are reaffirming that commitment with more energy than ever. Our mission to revolutionize the way drugs are discovered has been the driving force propelling us to lead boldly, and the results are evident.

Our flagships, KINETICfinder® and COVALfinder®, have changed the game in compound kinetic evaluation, allowing drug hunters to make informed decisions in the early stages of discovery, accelerating the process and propelling us to the forefront of innovation.

We cannot overlook the significant impact we've had by forging strong collaborations with academic institutions, small biotech firms, and major pharmaceutical companies worldwide. We take immense pride in contributing to the advancement of new drug research and improving patient health.

This exponential growth is not only reflected in our technological achievements but also in our human team. From day one, we've grown as a family of highly skilled, creative, and dedicated professionals who have propelled the company toward new horizons.

Thank you all for your unparalleled contribution to this extraordinary journey. Here we are, ready for the next ten years of innovation, discovery, and continued success!